Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
15,980,878
-
Share change
-
-52,650
-
Total reported value
-
$45,546,797
-
Put/Call ratio
-
115%
-
Price per share
-
$2.85
-
Number of holders
-
26
-
Value change
-
-$163,679
-
Number of buys
-
10
-
Number of sells
-
11
Institutional Holders of AC Immune SA - SHS (ACIU) as of Q3 2023
As of 30 Sep 2023,
AC Immune SA - SHS (ACIU) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,980,878 shares.
The largest 10 holders included
BVF INC/IL, Avidity Partners Management LP, MORGAN STANLEY, PLATINUM INVESTMENT MANAGEMENT LTD, WELLS FARGO & COMPANY/MN, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, Eversept Partners, LP, Assenagon Asset Management S.A., and Handelsbanken Fonder AB.
This page lists
26
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.